2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1770077612 MD
Verify on CMS →

MICHAEL IZZO, MD

Glaucoma Specialist (Ophthalmology) Physician in WYOMISSING, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
437
Medicare Part D claims · 166 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.3352/100
▲ 5 pts above national avg 83.1 · [object Object]
Industry payments
$645.73
25 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MICHAEL IZZO, MD reported a CMS MIPS final score of 88.3352/100 — above the 83.1 national average — and filed 437 Medicare Part D claims in 2023.

88.3352/100
MIPS score · +5 vs avg
437
Part D claims, 2023
66%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHAEL IZZO, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

88 Top 44% higher than 56% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MICHAEL IZZO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHAEL IZZO, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/14/2018

NPI 1770077612

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

437 85% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

88.3352/100 5.235200000000006% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Glaucoma Specialist (Ophthalmology) Physician share within Pennsylvania

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Pennsylvania

Medicare quality performance — MIPS

MICHAEL IZZO, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
88.3352/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 88.3352/100 vs national avg 83.1

0%100%National avg83%88.3%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 88.3352/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL IZZO, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in WYOMISSING, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1770077612. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL IZZO, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 1802 PAPERMILL RD, WYOMISSING, PA, 19610, with a listed phone of (610) 372-0712. NPI 1770077612 was issued on 06/14/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what IZZO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 437 prescription claims written by this provider, covering 166 Medicare beneficiaries and totaling roughly $40K in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.3352/100 for the 2023 performance year (Quality 91.6742, Cost 69.443), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1802 PAPERMILL RD
WYOMISSING, PA 19610

Provider Details

NPI 1770077612
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 06/14/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

88.3352
Final Score
Avg: 83.1
91.6742
Quality
69.443
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MICHAEL IZZO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BERKS EYE PHYSICIANS AND SURGEONS LTD
WYOMISSING, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL IZZO, MD. Source: openpaymentsdata.cms.gov.

Total received

$646

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MICHAEL IZZO, MD. To verify MICHAEL IZZO, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MICHAEL IZZO, MD — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 437 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

437
Total Claims
$40K
Total Drug Cost
166
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
630
Total Day Supply
17,219
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$33K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
1.55
Gender Split
69% female / 31% male
Age Distribution
<65: 20, 65-74: 72, 75-84: 52, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
75
Prednisolone Acetate
51
Brimonidine Tartrate
40
Dorzolamide Hcl
30
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
29
Timolol Maleate
26
Ketorolac Tromethamine
23
Ofloxacin
23
Rhopressa
Netarsudil Mesylate
17
Lumigan
Bimatoprost
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How MICHAEL IZZO, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

MICHAEL IZZO, MD's 437 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as IZZO.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL IZZO, MD's specialty?
MICHAEL IZZO, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in WYOMISSING, Pennsylvania. Credentials: MD.
How much does MICHAEL IZZO, MD prescribe under Medicare Part D?
In 2023, MICHAEL IZZO, MD wrote 437 Medicare Part D claims totaling $40K in drug costs for 166 beneficiaries.
What is MICHAEL IZZO, MD's Medicare quality score?
MICHAEL IZZO, MD has a CMS MIPS Final Score of 88.3352/100 (Quality: 91.6742, Cost: 69.443). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL IZZO, MD located?
MICHAEL IZZO, MD is located at 1802 PAPERMILL RD, WYOMISSING, PA, 19610. Phone: (610) 372-0712.
What is MICHAEL IZZO, MD's NPI number?
MICHAEL IZZO, MD's National Provider Identifier (NPI) is 1770077612, issued on 06/14/2018.
Does MICHAEL IZZO, MD prescribe more brand-name or generic drugs?
MICHAEL IZZO, MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $33K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does MICHAEL IZZO, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL IZZO, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL IZZO, MD accept Medicare?
MICHAEL IZZO, MD appears in CMS Medicare data with 437 Part D claims and 166 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL IZZO, MD's credentials?
MICHAEL IZZO, MD's NPI is 1770077612 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology